摘要
目的:分析莫西沙星联合甲硝唑用于治疗肺脓肿的临床效果,为临床治疗提供参考。方法:选择我院在2014年6月至2015年6月诊治的肺脓肿患者124例,根据治疗方法的不同将患者分为观察组和对照组患者各62例,观察组患者采用莫西沙星联合甲硝唑进行治疗,对照组患者选择甲硝唑进行治疗,比较两者患者的临床治疗效果。结果:观察组患者治疗总有效率为95.2%,对照组患者治疗总有效率为77.4%,观察组患者的治疗效果更好(P<0.05)。结论:选择莫西沙星联合甲硝唑治疗肺脓肿有着非常好的临床治疗效果,患者临床症状改善明显,恢复时间短,不良反应少,安全性高,有着积极的临床价值,值得推广。
Objective： To analyze the effect of moxifloxacin combined with metronidazole for the treatment of lung abscess. Methods： 124 cases pulmonary abscess diagnosed in Yichun Zhegan Friendship Hospital from June 2014 to June 2015 were divided into observation group and control group with 62 cases in each. The observed group was treated with moxifloxacin combined with metronidazole, while the control group was treated with metronidazole only. Results： The total effective rate was 95.2% in the observation group, while the control group was 77.4%; thus the combined treatment effect was better（P〈0.05）. Conclusion： The choice of moxifloxacin combined with metronidazole in treatment of pulmonary abscess has a very good clinical therapeutic effect. Clinical symptoms improved significantly,with shorter recovery time, less adverse reaction, high security, positive clinical value. Thus, it is worth popularizing.
出处
《药品评价》
CAS
2016年第9期37-38,51,共3页
Drug Evaluation
